Maruyama D, Omi A, Nomura F, Touma T, et al. Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance. Int J Hematol 2024;119:146-155.
PMID: 38195971